ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 234 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,780,000 | +143.2% | 68,990 | +403.6% | 0.02% | +133.3% |
Q4 2020 | $732,000 | +29.3% | 13,700 | 0.0% | 0.01% | +12.5% |
Q3 2020 | $566,000 | -81.3% | 13,700 | -78.0% | 0.01% | -81.0% |
Q2 2020 | $3,025,000 | +14.6% | 62,400 | -0.1% | 0.04% | 0.0% |
Q1 2020 | $2,639,000 | +2.9% | 62,450 | +0.2% | 0.04% | +61.5% |
Q4 2019 | $2,564,000 | +11.6% | 62,350 | -2.3% | 0.03% | +4.0% |
Q3 2019 | $2,298,000 | +34.6% | 63,850 | 0.0% | 0.02% | +38.9% |
Q2 2019 | $1,707,000 | -68.7% | 63,850 | -68.6% | 0.02% | -70.0% |
Q1 2019 | $5,453,000 | +64.8% | 203,082 | -0.8% | 0.06% | +39.5% |
Q4 2018 | $3,309,000 | -22.1% | 204,635 | 0.0% | 0.04% | +4.9% |
Q3 2018 | $4,248,000 | +4517.4% | 204,635 | +3310.6% | 0.04% | +4000.0% |
Q2 2018 | $92,000 | +124.4% | 6,000 | +230.2% | 0.00% | – |
Q1 2018 | $41,000 | -25.5% | 1,817 | 0.0% | 0.00% | -100.0% |
Q4 2017 | $55,000 | -19.1% | 1,817 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $68,000 | +33.3% | 1,817 | 0.0% | 0.00% | – |
Q2 2017 | $51,000 | -17.7% | 1,817 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $62,000 | +6100.0% | 1,817 | +20088.9% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 9 | -64.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 25 | +177.8% | 0.00% | – |
Q4 2015 | $1,000 | – | 9 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |